Agitation/Aggression in PMS and other ASD-related patient subpopulations are the main focus of Oryzon’s VANDAM project included in the Med4Cure IPCEI project
Read moreTime matters for patients in need, and new research shows integrated services can reduce Phase I-III study times by up to nearly three years, generating strong ROI for biotech and biopharma customers ...
Read moreSunRock Biopharma y Escugen han iniciado una colaboración estratégica para codesarrollar SRB123, un conjugado anticuerpo-fármaco (ADC, por sus siglas en inglés) first-in-class dirigido contra el r...
Read moreSince 2004, his laboratory has intensely studied cardiac progenitor cells, their origins and their therapeutic potential. Marbán’s discoveries make up the base of Deramiocel, a cell therapy product...
Read morePORTICO-2 designed to validate vafidemstat’s efficacy in reducing aggression in BPD patients
Read moreThe goal is to create protein nanoparticles that are useful in earlier cancer detection and to accelerate the development of more effective drugs with fewer side effects
Read moreInvestigadores del Cima Universidad de Navarra descubren que la administración de reguladores epigenéticos e inductores de muerte celular prolonga la supervivencia en modelos animales de cáncer
Read moreAnalytical method development in drug discovery refers to the process of designing, optimizing, and validating analytical techniques that can accurately characterize a drug candidate before it enters ...
Read moreAn international team of researchers has published results of a phase 2/3 clinical trial evaluating the efficacy and safety of leriglitazone, a new oral drug for the treatment of pediatric cerebral ad...
Read moreRPN-001 is a novel orally administered aromatase inhibitor being developed for the treatment of infertility in men with low serum testosterone
Read moreEl equipo, especialista en diseño y síntesis de nuevos compuestos bioactivos, se centrará en el desarrollo de inhibidores selectivos contra metiltransferasas de ARN, que se encuentran sobreexpresad...
Read moreOncomine Dx Express Test on the Ion Torrent Genexus Dx Integrated Sequencer generates results in as little as 24 hours to support timely therapy decisions
Read more